JWH-198
JWH-198 is a drug from the aminoalkylindole and naphthoylindole families which acts as a cannabinoid receptor agonist. It was invented by the pharmaceutical company Sanofi-Winthrop in the early 1990s. JWH-198 has a binding affinity at the CB1 receptor of 10 nM, binding around four times more tightly than the parent compound JWH-200, which has no substitution on the naphthoyl ring. It has been used mainly in molecular modelling of the cannabinoid receptors. In the United States, all CB1 receptor agonists of the 3-(1-naphthoyl)indole class such as JWH-198 are Schedule I Controlled Substances.
Link from a Wikipage to another Wikipage
primaryTopic
JWH-198
JWH-198 is a drug from the aminoalkylindole and naphthoylindole families which acts as a cannabinoid receptor agonist. It was invented by the pharmaceutical company Sanofi-Winthrop in the early 1990s. JWH-198 has a binding affinity at the CB1 receptor of 10 nM, binding around four times more tightly than the parent compound JWH-200, which has no substitution on the naphthoyl ring. It has been used mainly in molecular modelling of the cannabinoid receptors. In the United States, all CB1 receptor agonists of the 3-(1-naphthoyl)indole class such as JWH-198 are Schedule I Controlled Substances.
has abstract
JWH-198 is a drug from the ami ...... edule I Controlled Substances.
@en
CAS number
166599-76-4
FDA UNII code
J53IGM38PB
PubChem
Wikipage page ID
31,076,726
page length (characters) of wiki page
Wikipage revision ID
984,231,914
Link from a Wikipage to another Wikipage
CAS number
ChemSpiderID
IUPAC name
legal CA
Schedule II
@en
legal DE
NpSG
@en
legal UK
Class B
@en
legal US
Schedule I
@en
PubChem
10,319,620
SMILES
C4COCCN4CCn2ccCc3c1ccccc1ccc3
@en
StdInChIKey
QWHSUXWDDKWTOG-UHFFFAOYSA-N
@en
UNII
J53IGM38PB
@en
Verifiedfields
changed
@en
verifiedrevid
451,606,850
wikiPageUsesTemplate
subject
hypernym
comment
JWH-198 is a drug from the ami ...... edule I Controlled Substances.
@en
label
JWH-198
@en